BAYER AG
- Country
- 🇩🇪Germany
- Ownership
- Public
- Established
- 1863-08-01
- Employees
- 99.7K
- Market Cap
- $30.1B
- Website
- http://www.bayer.com
A Study to Evaluate the Pharmacokinetics (How it Moves Into, Through and Out From the Body) of a New Gadolinium-based Contrast Agent (GBCA) After Injection and How Safe it is in Participants With Normal and Impaired Renal Function
- Conditions
- Interventions
- First Posted Date
- 2021-09-30
- Last Posted Date
- 2022-11-21
- Lead Sponsor
- Bayer
- Target Recruit Count
- 24
- Registration Number
- NCT05061979
- Locations
- 🇺🇸
Alliance for Multispecialty Research, LLC - Knoxville, Knoxville, Tennessee, United States
🇺🇸Clinical Pharmacology of Miami, LLC, Miami, Florida, United States
A Study to Gather Information About the Progress and Outcomes of Pregnancy in Women Using Various Vitamin Support Plans Before and During Pregnancy
- First Posted Date
- 2021-09-30
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- Bayer
- Target Recruit Count
- 1500
- Registration Number
- NCT05062044
- Locations
- 🇺🇿
Many Locations, Multiple Locations, Uzbekistan
A Study to Learn How a Proton Pump Inhibitor Affects the Way Elinzanetant (BAY 3427080) Moves Into, Through and Out of the Body, and How Much of it Gets Absorbed by the Body When Taken as a Single and Small Radioactive Dose in Healthy Adults
- Conditions
- Interventions
- First Posted Date
- 2021-09-29
- Last Posted Date
- 2022-03-17
- Lead Sponsor
- Bayer
- Target Recruit Count
- 14
- Registration Number
- NCT05061563
- Locations
- 🇳🇱
PRAHealthSciences, Groningen, Netherlands
A Study to Learn How Well Darolutamide Administered Together With Androgen Deprivation Therapy (ADT) Works in Men With Metastatic Hormone-sensitive Prostate Cancer. Results Will be Compared With ADT Alone From a Previously Conducted Study.
- Conditions
- Interventions
- First Posted Date
- 2021-09-28
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Bayer
- Target Recruit Count
- 223
- Registration Number
- NCT05059236
- Locations
- 🇺🇸
MidLantic Urology - Bala Cynwyd, Bala-Cynwyd, Pennsylvania, United States
🇺🇸Urology Centers of Alabama, PC, Homewood, Alabama, United States
🇺🇸Arizona Urology Specialists, Tucson, Arizona, United States
A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease
- Conditions
- Interventions
- First Posted Date
- 2021-09-17
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Bayer
- Target Recruit Count
- 1584
- Registration Number
- NCT05047263
- Locations
- 🇺🇸
AdventHealth Translational Research Institute, Orlando, Florida, United States
🇺🇸Nephrology Associates of Northern Illinois and Indiana (NANI) - Hinsdale, Hinsdale, Illinois, United States
🇺🇸Dallas Renal Group - Medical City, Dallas, Texas, United States
A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause
- Conditions
- Interventions
- First Posted Date
- 2021-09-13
- Last Posted Date
- 2024-06-27
- Lead Sponsor
- Bayer
- Target Recruit Count
- 396
- Registration Number
- NCT05042362
- Locations
- 🇺🇸
Soapstone Center for Clinical Research, Decatur, Georgia, United States
🇺🇸HWC Women's Research Center | Englewood, OH, Englewood, Ohio, United States
🇺🇸Alliance for Multispecialty Research, LLC - Fort Meyers, Fort Myers, Florida, United States
A Study to Learn How Well a Monitoring System Called Continuous Glucose Monitoring (CGM) Which Measures Glucose on an Ongoing Basis Works and How Safe it is in Chinese Patients in Usual Practice
- Conditions
- Interventions
- First Posted Date
- 2021-09-09
- Last Posted Date
- 2023-03-09
- Lead Sponsor
- Bayer
- Target Recruit Count
- 76
- Registration Number
- NCT05038761
- Locations
- 🇨🇳
Many locations, Multiple Locations, Many Locations, China
🇨🇳Many Locations, Multiple Locations, China
A Study to Observe Treatment Patterns in Patients in Colombia Who Have Heart Failure
- First Posted Date
- 2021-09-08
- Last Posted Date
- 2022-12-15
- Lead Sponsor
- Bayer
- Target Recruit Count
- 1000
- Registration Number
- NCT05036967
- Locations
- 🇨🇴
Many Locations, Multiple Locations, Colombia
Prophylaxis Regimen for Hemophilia A Patients
- First Posted Date
- 2021-09-05
- Last Posted Date
- 2024-10-23
- Lead Sponsor
- Bayer
- Target Recruit Count
- 21
- Registration Number
- NCT05036278
- Locations
- 🇺🇸
Dr. Akshat Jain - Loma Linda University Medical Center, Loma Linda, California, United States
🇺🇸Orthopaedic Institute for Children, Los Angeles, California, United States
🇺🇸Loma Linda Children's Hospital, San Bernardino, California, United States
A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 52 Weeks in Women Who Have Been Through the Menopause
- Conditions
- Interventions
- First Posted Date
- 2021-09-01
- Last Posted Date
- 2024-03-15
- Lead Sponsor
- Bayer
- Target Recruit Count
- 628
- Registration Number
- NCT05030584
- Locations
- 🇺🇸
Mesa Obstetricians and Gynecologists, Mesa, Arizona, United States
🇺🇸David I Lubetkin, MD, LLC, Boca Raton, Florida, United States
🇺🇸HWC Women's Research Center, Englewood, Ohio, United States